Shares of hVIVO plc (LON:HVO – Get Free Report) dropped 6.8% during mid-day trading on Friday . The company traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). Approximately 2,518,262 shares traded hands during trading, a decline of 26% from the average daily volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.25).
hVIVO Price Performance
The firm has a market cap of £129.44 million, a P/E ratio of 634.17 and a beta of 0.97. The stock’s 50-day moving average is GBX 23.39 and its 200-day moving average is GBX 26.71. The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86.
hVIVO Company Profile
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Articles
- Five stocks we like better than hVIVO
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- 3 Legacy Tech Companies Reemerging as AI Leaders
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- What is the Euro STOXX 50 Index?
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
